BIR updates list of VAT-exempt drugs

Published March 17, 2022, 12:06 PM

by Jun Ramirez

The Bureau of Internal Revenue (BIR) released names of 22 additional drugs used for the treatment of six serious illnesses that are exempted from the 12 percent value-added tax (VAT).

BIR Commissioner Caesar R. Dulay came out with the list via Revenue Memorandum Circular No. 30-2022 based on a resolution of the Food and Drug Administration.

They are utilized to treat Covid-19, cancer, diabetes, hypertension, high cholesterol and mental illness.

The government exempts the medicines from VAT to effectively cut their retail prices.

They are Filgrastim, Follitropin Alfa (Lutropin Alfa), Sultuximab and Durvalumab for cancer; Desmopressin for Diabetes; Indapamide for hypertension; Ezetimibe for high cholesterol and Lemotrigine for mental illness.

For Covid-19: Arbidol Hydrochloride, Beeloniethasone, Bivalirudin, Casirivimab+Imdevimab, Dexamethasone (sodium phosphate), Enoxaparin, Exoxaparin, Heparin, Propofol, Remdesivir, Tinxaparin, Tocilizumab, Vancomycin HCI and medical grade oxygen.

 
CLICK HERE TO SIGN-UP
 

YOU MAY ALSO LIKE

["national","news","news"]
[2955055,3007534,3007530,3007524,3007521,3007482,3007511]